Nepal bans 47 immunosuppressant brands, doctors question move

Department of Drug Administration has cited safety concerns but doctors say the move could disrupt supplies of life-saving medicines for transplant patients.

In a sweeping decision, the Department of Drug Administration (DDA) has revoked the manufacturing licenses and registration certificates of 47 immunosuppressants brands at once. The department cited concerns over drug quality and safety, including the risk of cross-contamination at manufacturing facilities that lack dedicated production units for the medicines.